Relx PLC is not a strong buy at the moment for a beginner investor with a long-term strategy. While the company has positive developments in its business operations and hedge fund interest, the technical indicators suggest a neutral to slightly bearish trend in the short term. Additionally, the options data reflects bearish sentiment with a high put-call volume ratio. Considering the lack of strong buy signals from Intellectia Proprietary Trading Signals and the absence of recent congress trading data, it is advisable to hold off on investing in RELX at this time.
The MACD is positive and contracting, indicating a neutral to slightly bullish trend. RSI is at 72.371, suggesting the stock is nearing overbought territory. Moving averages are converging, signaling indecision in the market. Key resistance levels are at 35.188 and 36.43, while support levels are at 33.179 and 31.17.

Hedge funds are significantly increasing their positions in RELX, with a 147.40% increase in buying activity over the last quarter. Additionally, the company is expanding its integration with Epic, introducing AI-powered identity verification solutions, which could enhance its market position in the healthcare sector.
The stock has a 60% chance of declining in the short term, with potential losses of -1.57% in the next day, -3.55% in the next week, and -9.14% in the next month. Analyst price targets have been revised downward by some firms, and concerns over artificial intelligence competition have been noted.
No financial data was available for analysis.
Analysts are generally positive on RELX, with Overweight ratings from Morgan Stanley and JPMorgan. Deutsche Bank upgraded the stock to Buy, citing its high-quality data and technology business. However, price targets have been revised downward by some analysts, reflecting cautious optimism.